To unravel the mechanisms underlying the increased tumor promotion and progression observed in LRRK2 KI mice, we hypothesized that this mutation could enhance the susceptibility to DSS-induced colitis, thus promoting cancer pathogenesis. The gene discussed is LRRK2; the disease is neoplasm.